Reports from Hospital & Research Centre Highlight Recent Research in Type 2 Diabetes [Ischemia-Modified Albumin (IMA) for early detection of myocardial ischemia in acute coronary syndrome with type 2 diabetes mellitus: a case control study].

A recent case-control study conducted in Maharashtra, India, explored the use of Ischemia-Modified Albumin (IMA) as a potential biomarker for early detection of myocardial ischemia in patients with type 2 diabetes mellitus. The study found that IMA levels were significantly elevated in uncontrolled diabetic patients with early signs of myocardial ischemia. The researchers suggest that IMA estimation may improve the identification of ischemic patients who are missed by current diagnostic strategies or confidently rule out patients who do not have acute coronary syndrome. Further research is needed to validate these findings. [Extracted from the article]

Copyright of Heart Disease Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)